The COMPASS PWS was a 12-week, double-blind, randomized, placebo-controlled global Phase 3 trial that evaluated intranasal carbetocin 3.2 mg three times daily in 175 enrolled children and adults aged ...
Alibaba (NYSE:BABA) is also likely to be in the spotlight after the Chinese e-commerce giant unveiled its most powerful AI model to date, called Qwen3-Max, and vowed to increase investment in the ...
Investing.com -- The U.S. National Highway Traffic Safety Administration (NHTSA) has opened a preliminary evaluation into 17,198 Rivian electric delivery vans due to concerns about seat belt ...
Investing.com -- uniQure N.V. (NASDAQ:QURE) announced Wednesday it has entered into a $175 million non-dilutive senior secured term loan facility with Hercules Capital, Inc. (NYSE:HTGC) to enhance its ...
Investing.com -- The UK’s sale of five-year government debt was oversubscribed by the least in almost two years, signaling that high yields are not attracting buyers amid concerns about the country’s ...
Investing.com -- The European Commission plans to propose increased import tariffs on Russian oil, according to a Commission spokesperson’s statement on Wednesday. The spokesperson indicated that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results